List view / Grid view
Bristol Myers Squibb has received approval from the US FDA…
Bristol Myers Squibb has received approval from the US FDA to begin commercial production at its newest cell therapy manufacturing site.
Securing in-house viral vector production capabilities in the US is…
Securing in-house viral vector production capabilities in the US is set to help Bristol Myers Squibb manufacture its two CAR T-cell therapies.
The East Syracuse site will serve as the LOTTE Centre…
The East Syracuse site will serve as the LOTTE Centre for North America Operations for LOTTE’s new biologics contract development and manufacturing organisation (CDMO) business in the United States.
